biomedicina slovenica


pr=Čurin : 174

  1. Kern Petra; Čurin-Šerbec Vladka
    The challenges and limitations of choosing targets for CAR-T cell therapy
    2022
  2. Kovač Valerija; Černilec Maja; Čurin-Šerbec Vladka
    Toward a therapy of neurodegenerative diseases - a lesson learned from prion diseases
    2022
  3. Čurin-Šerbec Vladka; Režen Tadeja; Režen Tadeja
    Cross-border project for the efficient management of biobanks, C3B
    2022
  4. Kovač Valerija; Čurin-Šerbec Vladka
    Prion protein
    2022
  5. Šelb Julij; Rijavec Matija; Eržen Renato; Zidarn Mihaela; Kopač Peter; Škerget Matevž; Bajrović Nisera; Demšar Luzar Ajda; Park Young Hwan; Liu Yihui; Čurin-Šerbec Vladka; Zver Samo; Košnik Mitja; Lyons Jonathan J.; Korošec Peter
    Routine KIT p.D816V screening identifies clonal mast cell disease in Hymenoptera allergic patients regularly missed using baseline tryptase levels alone
    2021
  6. Omejec Sandra; Kovač Valerija; Černilec Maja; Gracar Melita; Šprohar Marjana; Čurin-Šerbec Vladka
    Optimizacija postopka za pripravo človeških monoklonskih protiteles iz periferne krvi dajalcev na modelu hepatitisa B
    2020
  7. Kovač Valerija; Černilec Maja; Šprohar Marjana; Gracar Melita; Rajčević Uroš; Omejec Sandra; Čurin-Šerbec Vladka
    Razvoj testa za določanje prisotnosti protiteles proti virusu SARS-CoV-2 v vzorcih plazme
    2020
  8. Dovč Tadeja; Poplašen Helena; Urbajs Matjaž; Čurin-Šerbec Vladka
    Določitev sekretorskega statusa in genotipa sistema Lewis iz vzorca krvi z metodo PCR v realnem času
    2020
  9. Maličev Elvira; Jež Mojca; Čurin-Šerbec Vladka; Sepčić Kristina
    Terapevtska biotehnologija
    2019
  10. Čurin-Šerbec Vladka
    Pot, ki smo jo prehodili od Georgesa Koehlerja in Cesarja Milsteina do Jamesa P. Allisona, Tasuka Honje in Sir Grega Winterja
    2018
  11. Čurin-Šerbec Vladka
    Towards a therapy of neurodegenerative diseases - a lesson learned from prion diseases
    2018
  12. Omejec Sandra; Kovač Valerija; Černilec Maja; Gracar Melita; Šprohar Marjana; Čurin-Šerbec Vladka
    Optimization of method for generating human monoclonal antibodies from single B cell isolated from vaccinated donors against Hepatitis B
    2018
  13. Šamec Neja; Komel Radovan; Čurin-Šerbec Vladka; Veranič Peter; Kos Janko
    Uporabnost nano-protiteles pri razvoju ciljanega zdravljenja glioblastoma
    [Implementation of nanobodies for the design of glioblastoma targeting therapy]
    2018
  14. Čurin-Šerbec Vladka
    Monoklonska protitelesa kot zdravilo
    2018
  15. Kovač Valerija; Čurin-Šerbec Vladka
    Prion proteins without the glycophosphatidylinositol anchor
    2017
  16. Bogožalec Košir Alexandra; Lukan Tjaša; Kukovec Mateja; Snoj Vivijana; Montanič Sendi; Čurin-Šerbec Vladka; Rajčević Uroš
    New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    [Novi monoklonski protitelesi proti bilitranslokazi kot diagnostično orodje pri ugotavljanju napredovanja svetloceličnega karcinoma ledvičnih celic]
    2017
  17. Razpotnik Rok; Novak Neža; Čurin-Šerbec Vladka; Rajčević Uroš
    Targeting malignant brain tumors with antibodies
    2017
  18. Čurin-Šerbec Vladka
    Predstavitev interregijskega projekta WELL LIVE(R)
    2017
  19. Bogožalec Košir Alexandra; Lukan Tjaša; Kukovec Mateja; Snoj Vivijana; Montanič Sendi; Čurin-Šerbec Vladka; Rajčević Uroš
    New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    [Novi monoklonski protitelesi proti bilitranslokazi kot diagnostično orodje pri ugotavljanju napredovanja svetloceličnega karcinoma ledvičnih celic]
    2017
  20. Čurin-Šerbec Vladka; Černilec Maja; Pretnar-Hartman Katrina; Kosmač Miha; Smrekar Boštjan; Vranac Tanja; Rajčević Uroš; Horvat Simon; Režen Tadeja
    Monoklonska protitelesa
    2017
  21. Kovač Valerija; Zupančič Blaž; Ilc Gregor; Plavec Janez; Čurin-Šerbec Vladka
    Truncated prion protein PrP226* - a structural view on its role in amyloid diseas
    2016
  22. Kovač Valerija; Hafner Bratkovič Iva; Čurin-Šerbec Vladka
    Anchorless forms of prion protein
    2016
  23. Čurin-Šerbec Vladka; Ihan Alojz; Kopitar Andreja Nataša; Simčič Saša; Stopinšek Sanja; Krošelj Manca
    Imunološki priročnik
    2016
  24. Kovač Valerija; Hafner Bratkovič Iva; Čurin-Šerbec Vladka
    Anchorless forms of prion protein - Impact of truncation on structure destabilization and prion protein conversion
    2016
  25. Amin Ladan; Nguyen Xuan T. A.; Rolle Irene Giulia; D'Este Elisa; Giachin Gabriele; Tran Thanh; Čurin-Šerbec Vladka; Cojoc Dan; Legname Giuseppe
    Characterization of prion protein function by focal neurite stimulation
    2016
  26. Filippi Antonio; Petrussa Elisa; Rajčević Uroš; Čurin-Šerbec Vladka; Passamonti Sabina; Renzone Giovanni; Scaloni Andrea; Zancani Marco; Vianello Angelo; Braidot Enrico
    Flavonoid interaction with a chitinase from grape berry skin
    2016
  27. Bricl Irena; Cukjati Marko; Ðorđević Suzana; Gregorc Cvetka; Rus Iskra Marjana; Vidan-Jeras Blanka; Lampreht Natalija; Mali Polonca; Novak Boštjan; Razboršek Irena; Levičnik-Stezinar Snežna; Čurin-Šerbec Vladka; Uran Apolonija; Železnik Klara; Korošec Primož
    Life flows
    2010
  28. Roncador Giovanna; Engel Pablo; Maestre Lorena; Anderson Amanda P.; Cordell Jacqueline L.; Cragg Mark S.; Čurin-Šerbec Vladka; Jones Margaret; Juranić Lisnić Vanda; Kremer Leonor
    The European antibody network's practical guide to finding and validating suitable antibodies for research
    2016
  29. Bricl Irena; Cukjati Marko; Ðorđević Suzana; Gregorc Cvetka; Rus Iskra Marjana; Vidan-Jeras Blanka; Lampreht Natalija; Mali Polona; Novak Boštjan; Razboršek Irena; Levičnik-Stezinar Snežna; Čurin-Šerbec Vladka; Uran Apolonija; Železnik Klara; Lampreht Natalija; Rožman Primož
    Z vami življenje teče dalje
    2015
  30. Čurin Anita; Žel Jurij; Divjak Mojca
    Ortotična oskrba psa po obsežni po obsežni poškodbi tarzalnega sklepa
    2015
  31. Didonna Alessandro; Colja Venturini Anja; Pretnar-Hartman Katrina; Vranac Tanja; Čurin-Šerbec Vladka; Legname Giuseppe
    Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
    2015
  32. Passamonti Sabina; Tramer Federica; Žiberna Lovro; Fornasaro Stefano; Čvorović Jovana; Martelanc Mitja; Franko Matjaž; Rajčević Uroš; Lukan Tjaša; Čurin-Šerbec Vladka
    Bilitranslocase membrane transporter
    2013
  33. Janež Nikolaja; Zaletel Eva; Kokošin Andreja; Vranac Tanja; Kovač Jasna; Vučković Darinka; Smole Možina Sonja; Čurin-Šerbec Vladka; Podgornik Aleš; Accetto Tomaž; Peterka Matjaž
    Opis in uporaba bakteriofagov kot protimikrobnih učinkovin za preprečevanje kampilobakterioz
    2014
  34. Rajčević Uroš; Bogožalec Alexandra; Lukan Tjaša; Kukovec Mateja; Snoj Vivijana; Montanič Sendi; Passamonti Sabina; Terdoslavich Michela; Čurin-Šerbec Vladka
    Characterization and use of monoclonal antibodies against bilitranslocase and its determination in clear cell renal cell carcinoma
    2014
  35. Montanič Sendi; Rajčević Uroš; Čurin-Šerbec Vladka
    Novel immuno - and stem cell-based therapies
    2014
  36. Rajčević Uroš; Bogožalec Alexandra; Lukan Tjaša; Kukovec Mateja; Snoj Vivijana; Montanič Sendi; Passamonti Sabina; Terdoslavich Michela; Čurin-Šerbec Vladka
    Characterization and use of monoclonal antibodies against bilitranslocase and its determination in the progress of clear cell renal cell carcinoma
    2014
  37. Lukan Anja; Černilec Maja; Vranac Tanja; Popović Mara; Čurin-Šerbec Vladka
    Regional distribution of anchorless prion protein, PrP226*, in the human brain
    2014
  38. Peresson Carlo; Rajčević Uroš; Montanič Sendi; Čurin-Šerbec Vladka
    Involvement of mammalian bilitranslocase-like protein(s) in chlorophyll catabolism of Pisum sativum L. tissues
    2014
  39. Montanič Sendi; Čurin-Šerbec Vladka; Passamonti Sabina
    Peptidi A, B in C so pomembni za strukturo in delovanje jetrne bilitranslokaze
    [Peptides A, B and C are important for the structure and function of liver bilitranslocase]
    2013
  40. Dvorakova Eva; Vranac Tanja; Janouskova Olga; Černilec Maja; Koren Simon; Lukan Anja; Nováková Jana; Matej Radoslav; Holada Karel; Čurin-Šerbec Vladka
    Detection of the GPI-anchorless prion protein fragment PrP226* in human brain
    2013
  41. Černilec Maja; Čurin-Šerbec Vladka; Rožman Primož; Glonar Ljerka
    Monoclonal antibodies against A B 0 blood group antigens
    1993
  42. Žiberna Lovro; Kim Jong-Hun; Auger Cyril; Drevenšek Gorazd; Montanič Sendi; Čurin-Šerbec Vladka; Tramer Federica; Passamonti Sabina; Schini-Kerth Valérie
    Functional role of bilitranslocase in endothelium-dependent no- and EDHF-mediated relaxations of coronary arteries and eNOS activation by flavonoids
    2011
  43. Lukan Anja; Vranac Tanja; Čurin-Šerbec Vladka
    TSE diagnostics
    2013
  44. Montanič Sendi; Terdoslavich Michela; Rajčević Uroš; De Leo Luigina; Bonin Serena; Čurin-Šerbec Vladka; Passamonti Sabina
    Development and characterization of novel mAb against bilitranslocase - a new biomarker of renal carcinoma
    2013
  45. Passamonti Sabina; Novič Marjana; Legname Giuseppe; Franko Mladen; Borgna Caterina; Bandiera Franca; Klemenc Matjaž; Ugo Paolo; Braidot Enrico; Not Tarcisio; Čurin-Šerbec Vladka; Milošev Ingrid; Čemažar Maja
    TRANS2CARE
    2013
  46. Montanič Sendi; Terdoslavich Michela; Rajčevič uroš; De Leo Luigina; Bonin Serena; Čurin-Šerbec Vladka; Passamonti Sabina
    Development and characterization of novel mAb against bilitranslocase - a new biomarker of renal carcinoma
    2013
  47. Čurin-Šerbec Vladka
    Brez eksperimentalnih živali ne bi bilo sodobnih diagnostičnih reagentov in mnogih drugih znanstvenih odkritij
    [Experimental animals were perequisite for the development of modern diagnostic reagents and many scientific discoveries]
    2013
  48. Škrlj Nives; Drevenšek Gorazd; Hudoklin Samo; Romih Rok; Čurin-Šerbec Vladka; Dolinar Marko
    Recombinant single-chain antibody with the trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier
    2013
  49. Černilec Maja; Dvorakova Eva; Janouskova Olga; Vranac tanja; Lukan Anja; Hobzova Kristyna; Čurin-Šerbec Vladka; Holada Karel
    PrP226*, the truncated form of PrP, as a marker for Creutzfeldt-Jakob disease
    2012
  50. Delneri A; Franca R; Terdoslavich M; Montanič S; Čurin-Šerbec V; Tramer F; Francese M; Passamonti S
    Identification and functional characterization of bilitranslocase in sea-bass (Dicentrarchus labrax) hepatopancreas
    2011
  51. Mori J; Vranac T; Smrekar B; Černilec M; Čurin-Šerbec V; Horvat S; Ihan A; Benčina M; Jerala R
    Activation of innate and adaptive immune response by chimeric flagellin
    2011
  52. Kosmač Miha; Avčin Tadej; Toplak Nataša; Simonini Gabriele; Cimaz Ronaldo; Čurin-Šerbec Vladka
    Exploring the binding sites of anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    2011
  53. Kosmač Miha; Avčin Tadej; Toplak Nataša; Simonini Gabriele; Cimaz Rolando; Čurin-Šerbec Vladka
    Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    2010
  54. Kosmač Miha; Koren Simon; Giachin Gabriele; Stoilova Tatiana; Gennaro Renato; Legname Giuseppe; Čurin-Šerbec Vladka
    Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment
    2011
  55. Škrlj Nives; Vranac Tanja; Popović Mara; Čurin-Šerbec Vladka; Dolinar Marko
    Humanized PrPSc-specific antibody fragments-A step towards human prion disease therapy
    2010
  56. Koren S; Kosmač M; Colja-Venturini A; Montanič S; Škrlj N; Dolinar M; Čurin-Šerbec V
    Antibody variable-region sequencing: a method of choice for hybridoma cell-line authentication
    2009
  57. Vranac T; Ghielmetti M; Čurin-Šerbec V
    Prion protein peptides as vaccines
    2009
  58. Kosmač Miha; Koren Simon; Škrlj Nives; Dolinar Marko; Čurin-Šerbec Vladka
    Antibody variable-region sequencing for hybridoma authentication
    2009
  59. Trontelj Katja; Ušaj Marko; Čurin-Šerbec Vladka; Miklavčič Damjan
    Zlivanje celic z elektrofuzijo
    [Cell electrofusion]
    2010
  60. Kotnik V; Čurin-Šerbec V; Hartman-Pretnar K; Ihan A; Jeras M; Kopitar AN; Malovrh T; Simčič S; Stopinšek S; Skvarč M; Vidan-Jeras B; Wraber B
    Imunološki priročnik
    2010
  61. Colja-Venturini Anja; Bresjanac Maja; Vranac Tanja; Koren Simon; Narat Mojca; Popović Mara; Čurin-Šerbec Vladka
    Anti-idiotypic antibodies: a new approach in prion research
    2009
  62. Ghielmetti M; Vranac T; Čurin-Šerbec V
    Prion protein peptides as vaccines
    2009
  63. Ramagopalan Sreeram V; Cukjati Marko; Černilec Maja; DeLuca Gabriele C; Dyment David A; Degenhardt Alexandra; Sadovnick A Dessa; Čurin-Šerbec Vladka; Ebers George C; Duquette Pierre
    Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis
    2008
  64. Cukjati M; Vaupotič T; Rupreht R; Čurin-Šerbec V
    Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay
    2007
  65. Koren Simon; Kosmač Miha; Colja-Venturini Anja; Montanič Sendi; Čurin-Šerbec Vladka
    Antibody variable-region sequencing as a method for hybridoma cell-line authentication
    2008
  66. Koren Simon; Cukjati Marko; Černilec Maja; Vidan-Jeras Blanka; Rupreht Ruth; Čurin-Šerbec Vladka
    First case of a homozygous frameshift deletion in HFE associated with hemochromatosis
    2007
  67. Kosmač Miha; Bratkovič Tomaž; Štrukelj Borut; Čurin-Šerbec Vladka
    Mapping the epitope of a PrPSc-specific monoclonal antibody using phage-displayed random peptides
    2007
  68. Colja-Venturini Anja; Pretnar-Hartman Katrina; Narat Mojca; Čurin-Šerbec Vladka
    Antiidiotypic approach in prion biology
    2007
  69. Černilec Maja; Vranac Tanja; Hafner-Bratkovič Iva; Koren Simon; Venturini-Colja Anja; Popović Mara; Juntes Polona; Čurin-Šerbec Vladka
    Identification of an epitope on the recombinant bovine PrP that is able to elicit a prominent immune response in wild-type mice
    2007
  70. Čurin-Šerbec Vladka
    Slovenia funding schemes for young researchers
    2001
  71. Čurin-Šerbec Vladka
    Antibodies capable to selectively detect prion Prp Sc isoforms
    2006
  72. Cukjati M; Koren S; Čurin Šerbec V; Vidan-Jeras B; Rupreht R
    A novel homozygous frameshift deletion c.471del of HFE associated with hemochromatosis
    2007
  73. He T; Nie Y; Ge Y; Xie R; Yuan T; Wang Y; Galvani Vesna; Rupreht R; Čurin-Šerbec Vladka
    Expression of human-mouse chimeric antibody against TNF-alpha in CHO cells
    2005
  74. Čurin-Šerbec Vladka; Černilec Maja; Gracar Melita; Hartman-Pretnar Katrina; Montanič Sendi; Smrekar Boštjan; Šprohar Marjana
    Monoklonska protitelesa v transfuzijski medicini
    2007
  75. Čurin-Šerbec Vladka; Rožman Primož; Glonar Ljerka; Gubenšek Franc
    Monoklonska protitelesa v medicinski diagnostiki in profilaksi
    1991
  76. Čurin-Šerbec V; Černilec M; Pretnar-Hartman K; Venturini A; Vranac T
    Some new aspects of humoral immune response to prion proteins and peptides, leading to powerful monoclonal antibodies
    2006
  77. Venturini A; Koren S; Vranac T; Omahen L; Narat M; Čurin-Šerbec V
    Antidiotypic antibodies against PRPSC - specific monoclonal antibody
    2006
  78. Koren S; Kosmač M; Pretnar-Hartman K; Vranac T; Čurin-Šerbec V
    Immunisation with a human prion protein peptide stimulates generation of identical PRPsc-specific antibodies in distinct mice
    2006
  79. Černilec M; Venturini A; Koren S; Hafner-Bratkovič I; Čurin-Šerbec V
    Determination of an epitope on the recombinant bovine PRP that provokes the immune response in wild-type mice
    2006
  80. Vranac Tanja; Hartman-Pretnar Katrina; Popović Mara; Venturini Anja; Žerovnik Eva; Čurin-Šerbec Vladka
    A single prion protein peptide can elicit a panel of isoform specific monoclonal antibodies
    2006
  81. Venturini Anja; Koren Simon; Hartman-Pretnar Katrina; Galvani Vesna; Čurin-Šerbec Vladka
    Determination of prion protein in human blood with a panel of monoclonal antibodies
    2005
  82. Vranac Tanja; Hafner Iva; Popović Mara; Jerala Roman; Čurin-Šerbec Vladka
    The immune response to prion protein peptide, expressed as a fusion protein
    2004
  83. Pretnar-Hartman Katrina; Venturini Anja; Galvani Vesna; Koren Simon; Rupreht Ruth; Čurin-Šerbec Vladka
    Panel of monoclonal antibodies discriminates between human and bovine brain PrP, recombinant PrPs and glycosilation patterns
    2004
  84. Černilec Maja; Vranac Tanja; Rupreht Ruth; Popović Mara; Juntes Polona; Čurin-Šerbec Vladka
    No PrP-null mice are needed to obtain specific monoclonal antibodies against recombinant bovine PrP
    2004
  85. Galvani Vesna; Rupreht Ruth; Čurin-Šerbec Vladka
    Risk factors associated with CJD in Slovenians and a real-time PCR method for PRNP gene codon 129 SNP
    2004
  86. Vranac Tanja; Čurin-Šerbec Vladka; Popović Mara
    A single synthetic peptide can elicit a panel of mAbs against different conformations of PrP
    2005
  87. Pretnar-Hartman Katrina; Čurin-Šerbec Vladka
    Properties of the PrPSc - specific mAb V5B2 guarantee a useful diagnostic tool
    2005
  88. Poklar-Ulrih Nataša; Skrt Mihaela; Veranič Peter; Galvani Vesna; Vranac Tanja; Čurin-Šerbec Vladka
    Oligomeric forms of peptide fragment PrP(214-226) in solution are preferentially recognized by PrPSc-specific antibody
    2006
  89. Poklar Nataša; Skrt Mihaela; Veranič Peter; Galvani Vesna; Čurin-Šerbec Vladka
    Conformation-dependent recognition of peptide fragment PrP(214-226) by PrPSc-specific antibody
    2005
  90. Venturini Anja; Koren Simon; Hartman-Pretnar Katrina; Černilec Maja; Čurin-Šerbec Vladka
    Determination of prion protein in human blood with a panel of monoclonal antibodies
    2005
  91. Montanič Sendi; Volgemut Aleš; Taiping He; Galvani Vesna; Menart Viktor; Poklar-Ulrih Nataša; Čurin-Šerbec Vladka
    Humanised monoclonal antibody against TNFalpha as a potential therapeutic agent
    2005
  92. Čurin-Šerbec Vladka
    Testi za določanje krvne skupine AB0 in RhD
    2003
  93. Čurin-Šerbec Vladka
    Antigenic properties of prion peptides
    2004
  94. Rupreht R; Cukjati M; Vaupotič T; Galvani V; Lukič L; Čurin-Šerbec V
    High-troughput genotyping of 193A>T (S65C), 187C>G (H63D) and 845G>A (C282Y) in HFE gene using novel MGB probes
    2004
  95. Poklar-Ulrih N; Skrt M; Milek I; Veranič P; Galvani V; Černilec M; Pretnar-Hartman K; Čurin-Šerbec V
    Unusual behaviour of a peptide segment from the primary structure of human prion protein
    2004
  96. Čurin-Šerbec Vladka
    Monoclonal antibodies against TNF-alpha in diagnostics and therapy
    [Monoklonska protitelesa proti TNF-alfa v diagnostiki in terapiji]
    2004
  97. Vajs A; Smrkolj M; Sitar-Čurin A; Grčman M
    Study of polymorphism of 1-cyclopropyl-6-fluoro-1,4-dihydro-8-metoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
    2003
  98. Čurin-Šerbec Vladka; Bresjanac Mara; Popović Mara; Pretnar-Hartman Katarina; Galvani Vesna; Rupreht Ruth; Černilec Maja; Vranac Tanja; Hafner Iva; Jerala Roman
    Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue
    2004
  99. Flegel WA; Čurin-Šerbec V; Delamaire M; Donvito B; Ikeda H; Jorgensen J; Kumpel B; Le-Pennec P-Y; Pisačka M; Tani Y
    Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination
    2002
  100. Čurin-Šerbec Vladka; Menart Viktor; Gaberc-Porekar Vladimira; Štalc Anton; Žunec Petra; Ocvirk Janja; Štabuc Borut
    Monoclonal antibodies against soluble TNF-alpha receptors p55 and p75 as well as against TNF-alpha and its analogues
    2003

1 101  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics